Cargando…

Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production

PURPOSE: To document the clinical profile of patients with keratitis due to Aspergillus flavus and to elaborate on differences in the aflatoxin-producing potential of keratitis strains versus environmental strains of A. flavus. METHODS: Over a 6-month period, strains of Aspergillus flavus were isola...

Descripción completa

Detalles Bibliográficos
Autores principales: Leema, George, Kaliamurthy, Jayaraman, Geraldine, Pitchairaj, Thomas, Philip A.
Formato: Texto
Lenguaje:English
Publicado: Molecular Vision 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866576/
https://www.ncbi.nlm.nih.gov/pubmed/20461152
_version_ 1782180933105876992
author Leema, George
Kaliamurthy, Jayaraman
Geraldine, Pitchairaj
Thomas, Philip A.
author_facet Leema, George
Kaliamurthy, Jayaraman
Geraldine, Pitchairaj
Thomas, Philip A.
author_sort Leema, George
collection PubMed
description PURPOSE: To document the clinical profile of patients with keratitis due to Aspergillus flavus and to elaborate on differences in the aflatoxin-producing potential of keratitis strains versus environmental strains of A. flavus. METHODS: Over a 6-month period, strains of Aspergillus flavus were isolated in culture from corneal scrape or biopsy material of patients who presented with suppurative keratitis (clinical isolates). The strains were confirmed to be A. flavus by molecular methods (amplification of the internal transcribed spacer 2 [ITS 2] region and direct sequencing followed by comparative GenBank analysis). The aflatoxin-producing potential of each strain was determined by thin-layer chromatography. The ability of each strain to form sclerotia in Czapek-Dox agar (CDA) after 7 days incubation at 30 °C in the dark and to produce a beige ring in yeast extract sucrose agar supplemented with methyl β-cyclodextrin and sodium desoxycholate (YESD medium) after 3 days incubation at 30 °C was also assessed. For comparison, the tests were also run on 10 strains of A. flavus (identity confirmed by molecular methods) collected from local farming areas (environmental isolates). RESULTS: Aflatoxin B1 was detected in 16 (80%) of 20 culture filtrate or mycelial homogenate samples of the clinical isolates (mean concentration: 366.7±125.4 parts per billion [ppb]) but in only eight (40%) of 20 samples of environmental isolates (mean concentration: 306.6±125.4 ppb). Seven of the eight aflatoxin-producing clinical isolates and two of the four aflatoxin-producing environmental isolates formed sclerotia (>400 μm) and a beige ring in culture. CONCLUSIONS: Aflatoxin B1 was detected in a significantly higher percentage of growth samples of clinical isolates (80%) than growth samples of environmental isolates (40%) (χ(2)=6.667; p=0.0098); the therapeutic implications of this finding require further study. The production of sclerotia and a beige ring in culture appear to be useful markers of aflatoxin-producing potential in strains of A. flavus isolated from keratitis.
format Text
id pubmed-2866576
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-28665762010-05-11 Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production Leema, George Kaliamurthy, Jayaraman Geraldine, Pitchairaj Thomas, Philip A. Mol Vis Research Article PURPOSE: To document the clinical profile of patients with keratitis due to Aspergillus flavus and to elaborate on differences in the aflatoxin-producing potential of keratitis strains versus environmental strains of A. flavus. METHODS: Over a 6-month period, strains of Aspergillus flavus were isolated in culture from corneal scrape or biopsy material of patients who presented with suppurative keratitis (clinical isolates). The strains were confirmed to be A. flavus by molecular methods (amplification of the internal transcribed spacer 2 [ITS 2] region and direct sequencing followed by comparative GenBank analysis). The aflatoxin-producing potential of each strain was determined by thin-layer chromatography. The ability of each strain to form sclerotia in Czapek-Dox agar (CDA) after 7 days incubation at 30 °C in the dark and to produce a beige ring in yeast extract sucrose agar supplemented with methyl β-cyclodextrin and sodium desoxycholate (YESD medium) after 3 days incubation at 30 °C was also assessed. For comparison, the tests were also run on 10 strains of A. flavus (identity confirmed by molecular methods) collected from local farming areas (environmental isolates). RESULTS: Aflatoxin B1 was detected in 16 (80%) of 20 culture filtrate or mycelial homogenate samples of the clinical isolates (mean concentration: 366.7±125.4 parts per billion [ppb]) but in only eight (40%) of 20 samples of environmental isolates (mean concentration: 306.6±125.4 ppb). Seven of the eight aflatoxin-producing clinical isolates and two of the four aflatoxin-producing environmental isolates formed sclerotia (>400 μm) and a beige ring in culture. CONCLUSIONS: Aflatoxin B1 was detected in a significantly higher percentage of growth samples of clinical isolates (80%) than growth samples of environmental isolates (40%) (χ(2)=6.667; p=0.0098); the therapeutic implications of this finding require further study. The production of sclerotia and a beige ring in culture appear to be useful markers of aflatoxin-producing potential in strains of A. flavus isolated from keratitis. Molecular Vision 2010-05-11 /pmc/articles/PMC2866576/ /pubmed/20461152 Text en Copyright © 2010 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Leema, George
Kaliamurthy, Jayaraman
Geraldine, Pitchairaj
Thomas, Philip A.
Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title_full Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title_fullStr Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title_full_unstemmed Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title_short Keratitis due to Aspergillus flavus: Clinical profile, molecular identification of fungal strains and detection of aflatoxin production
title_sort keratitis due to aspergillus flavus: clinical profile, molecular identification of fungal strains and detection of aflatoxin production
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866576/
https://www.ncbi.nlm.nih.gov/pubmed/20461152
work_keys_str_mv AT leemageorge keratitisduetoaspergillusflavusclinicalprofilemolecularidentificationoffungalstrainsanddetectionofaflatoxinproduction
AT kaliamurthyjayaraman keratitisduetoaspergillusflavusclinicalprofilemolecularidentificationoffungalstrainsanddetectionofaflatoxinproduction
AT geraldinepitchairaj keratitisduetoaspergillusflavusclinicalprofilemolecularidentificationoffungalstrainsanddetectionofaflatoxinproduction
AT thomasphilipa keratitisduetoaspergillusflavusclinicalprofilemolecularidentificationoffungalstrainsanddetectionofaflatoxinproduction